Cargando…
A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models
Psoriasis is characterized by abnormal proliferation of keratinocytes, as well as infiltration of immune cells into the dermis and epidermis, causing itchy, scaly and erythematous plaques of skin. The understanding of this chronic inflammatory skin disease remains unclear and all available treatment...
Autores principales: | Jin, Jing, Xue, Nina, Liu, Yuan, Fu, Rong, Wang, Mingjin, Ji, Ming, Lai, Fangfang, Hu, Jinping, Wang, Xiaojian, Xiao, Qiong, Zhang, Xiaoying, Yin, Dali, Bai, Liping, Chen, Xiaoguang, Rao, Shuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016294/ https://www.ncbi.nlm.nih.gov/pubmed/32082973 http://dx.doi.org/10.1016/j.apsb.2019.11.006 |
Ejemplares similares
-
Sphingosine-1-Phosphate Receptor Subtype 1 (S1P1) Modulator IMMH001 Regulates Adjuvant- and Collagen-Induced Arthritis
por: Jin, Jing, et al.
Publicado: (2019) -
Metabolism and Interspecies Variation of IMMH-010, a Programmed Cell Death Ligand 1 Inhibitor Prodrug
por: Wang, Yuchen, et al.
Publicado: (2021) -
Pharmacokinetics of H002, a novel S1PR(1) modulator, and its metabolites in rat blood using liquid chromatography–tandem mass spectrometry
por: Mi, Jiaqi, et al.
Publicado: (2016) -
Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis
por: Freitas, Elisangela Oliveira, et al.
Publicado: (2015) -
Simultaneous Determination of a Novel PD-L1 Inhibitor, IMMH-010, and Its Active Metabolite, YPD-29B, in Rat Biological Matrices by Polarity-Switching Liquid Chromatography-Tandem Mass Spectrometry: Application to ADME Studies
por: Jiang, Jianwei, et al.
Publicado: (2021)